(QLYS) Qualys - NASDAQ
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 3.920m USD | Total Return: -13.1% in 12m
Avg Turnover: 75.8M
EPS Trend: 97.1%
Qual. Beats: 16
Rev. Trend: 99.9%
Qual. Beats: 3
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Qualys, Inc. (NASDAQ: QLYS) is a cloud-based provider of IT, security, and compliance solutions serving customers in the United States and internationally. The company offers a broad suite of Qualys Cloud Apps covering cybersecurity asset management, vulnerability management, detection and response, patch management, endpoint detection, policy compliance, and file integrity monitoring, alongside its TotalCloud platform for cloud-native application and workload protection, including Kubernetes and container security.
At the core of the offering is the Enterprise TruRisk platform, which helps customers identify and prioritize IT and operational technology assets, quantify cyber risk exposure, and track remediation efforts. The company sells to enterprises, government entities, and small and medium-sized businesses across sectors such as financial services, healthcare, manufacturing, and government, distributing through direct sales teams as well as managed service providers, resellers, and consulting firms. Founded in 1999 and headquartered in Foster City, California, Qualys operates within the Systems Software sub-industry of the broader Information Technology sector, where it competes in the cybersecurity and cloud security posture management markets that have grown steadily as organizations consolidate fragmented security tools onto unified cloud-native platforms.
- TotalCloud CNAPP adoption accelerates multi-product revenue growth
- Enterprise TruRisk platform upsell expands average deal size
- SEC cybersecurity disclosure rules boost enterprise compliance spending
| Net Income: 201.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA -0.17 > 1.0 |
| NWC/Revenue: 28.79% < 20% (prev 27.33%; Δ 1.45% < -1%) |
| CFO/TA 0.27 > 3% & CFO 295.1m > Net Income 201.4m |
| Net Debt (-419.1m) to EBITDA (266.9m): -1.57 < 3 |
| Current Ratio: 1.43 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.7m) vs 12m ago -3.00% < -2% |
| Gross Margin: 83.22% > 18% (prev 81.79%; Δ 1.43% > 0.5%) |
| Asset Turnover: 65.60% > 50% (prev 62.39%; Δ 3.21% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.18 (Total Current Assets 656.6m - Total Current Liabilities 459.2m) / Total Assets 1.09b |
| B: -0.15 (Retained Earnings -167.3m / Total Assets 1.09b) |
| C: 0.24 (EBIT TTM 253.5m / Avg Total Assets 1.05b) |
| D: 1.09 (Book Value of Equity 569.9m / Total Liabilities 524.8m) |
| Altman-Z'' = 3.45 = A |
| DSRI: 1.01 (Receivables 134.9m/121.6m, Revenue 685.9m/621.7m) |
| GMI: 0.98 (GM 81.79% / 83.22%) |
| AQI: 1.03 (AQ_t 0.34 / AQ_t-1 0.33) |
| SGI: 1.10 (Revenue 685.9m / 621.7m) |
| TATA: -0.09 (NI 201.4m - CFO 295.1m) / TA 1.09b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of June 28, 2026, the stock is trading at USD 123.27 with a total of 1,608,462 shares traded. Over the past week, the price has changed by +10.75%, over one month by +20.49%, over three months by +35.30% and over the past year by -13.06%.
Current recommended Stop Loss: 114.30 (which is 7.3% or 1.8 ATR below the current price).
Qualys has received a consensus analysts rating of 3.17. Therefore, it is recommended to hold QLYS.
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 107.4 | -12.9% |
P/E Trailing = 19.982
P/E Forward = 14.8588
P/S = 5.7233
P/B = 6.8849
P/EG = 4.3719
Revenue TTM = 685.9m USD
EBIT TTM = 253.5m USD
EBITDA TTM = 266.9m USD
Long Term Debt = 44.6m USD (estimated: total debt 52.2m - short term 7.62m)
Short Term Debt = 7.62m USD (from shortTermDebt, last quarter)
Debt = 52.2m USD (from shortLongTermDebtTotal, last quarter) (leases 52.2m already included)
Net Debt = -419.1m USD (calculated: Debt 52.2m - CCE 471.3m)
Enterprise Value = 3.50b USD (3.92b + Debt 52.2m - CCE 471.3m)
Interest Coverage Ratio = unknown (Ebit TTM 253.5m / Interest Expense TTM 0.0)
EV/FCF = 12.17x (Enterprise Value 3.50b / FCF TTM 287.7m)
FCF Yield = 8.22% (FCF TTM 287.7m / Enterprise Value 3.50b)
FCF Margin = 41.94% (FCF TTM 287.7m / Revenue TTM 685.9m)
Net Margin = 29.37% (Net Income TTM 201.4m / Revenue TTM 685.9m)
Gross Margin = 83.22% ((Revenue TTM 685.9m - Cost of Revenue TTM 115.1m) / Revenue TTM)
Gross Margin QoQ = 83.43% (prev 83.36%)
Tobins Q-Ratio = 3.20 (Enterprise Value 3.50b / Total Assets 1.09b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 52.2m)
Taxrate = 20.54% (52.1m / 253.5m)
NOPAT = 201.4m (EBIT 253.5m * (1 - 20.54%))
Current Ratio = 1.42 (Total Current Assets 656.6m / Total Current Liabilities 461.5m)
Debt / Equity = 0.09 (Debt 52.2m / totalStockholderEquity, last quarter 569.9m)
Debt / EBITDA = -1.57 (Net Debt -419.1m / EBITDA 266.9m)
Debt / FCF = -1.46 (Net Debt -419.1m / FCF TTM 287.7m)
Total Stockholder Equity = 542.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.27% (Net Income 201.4m / Total Assets 1.09b)
RoE = 37.15% (Net Income TTM 201.4m / Total Stockholder Equity 542.1m)
RoCE = 43.21% (EBIT 253.5m / Capital Employed (Equity 542.1m + L.T.Debt 44.6m))
RoIC = 33.09% (NOPAT 201.4m / Invested Capital 608.8m)
WACC = 9.23% (E(3.92b)/V(3.97b) * Re(9.35%) + D(52.2m)/V(3.97b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 9.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -100.00 | Cagr: -2.47%
[DCF] Terminal Value 73.65% ; FCFF base≈278.0m ; Y1≈300.3m ; Y5≈368.1m
[DCF] Fair Price = 151.0 (EV 4.90b - Net Debt -419.1m = Equity 5.32b / Shares 35.2m; r=9.23% [WACC]; 5y FCF grow 9.15% → 2.50% )
EPS Correlation: 97.06 | EPS CAGR: 18.31% | SUE: 2.42 | # QB: 16
Revenue Correlation: 99.95 | Revenue CAGR: 9.98% | SUE: 2.02 | # QB: 3
EPS current Quarter (2026-06-30): EPS=1.78 | Chg30d=+0.46% | Revisions=-18% | Analysts=21
EPS next Quarter (2026-09-30): EPS=1.91 | Chg30d=+0.99% | Revisions=+39% | Analysts=21
EPS current Year (2026-12-31): EPS=7.57 | Chg30d=+0.00% | Revisions=+83% | GrowthEPS=+7.1% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=8.26 | Chg30d=+0.00% | Revisions=+83% | GrowthEPS=+9.1% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: +83%